Structured evidence table for Coq10 Arterial Stiffness Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Coq10 Arterial Stiffness Randomized Trial | In order to reduce the risk of thrombosis, patients with atherosclerotic cardiovascular disease are often prescribed antiplatelet therapy. | 3 | Dobre Maria-Zinaida (2025) | Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks |
| Coq10 Arterial Stiffness Randomized Trial | Nevertheless, platelet aggregation inhibition can also result in an increased bleeding risk, which is why the clinical approach must consider the benefit of single or dual antiplatelet treatments. | 3 | Dobre Maria-Zinaida (2025) | Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks |
| Coq10 Arterial Stiffness Randomized Trial | The bleeding risk in atherosclerosis can arise from plaque rupture or the presence of intraplaque hemorrhage. | 3 | Dobre Maria-Zinaida (2025) | Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks |
| Coq10 Arterial Stiffness Randomized Trial | 1 2 3 The development of atherosclerosis, an essential promoter of cardiovascular diseases and stroke via thrombus formation [], is supported by the interplay between platelets and endothelial cells []. | 3 | Dobre Maria-Zinaida (2025) | Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks |
| Coq10 Arterial Stiffness Randomized Trial | Importantly, these biological changes manifest most meaningfully through declines in functional capacity, including reduced muscle strength, impaired metabolic regulation, diminished cognitive performance, and increased disease risk. | 4 | Kurtz Jennifer A. (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits |
| Coq10 Arterial Stiffness Randomized Trial | This article aims to synthesize evidence from human studies evaluating dietary supplements that directly or indirectly modulate the recognized hallmarks of aging, such as mitochondrial dysfunction, oxidative stress, inflammation, and proteostasis. | 4 | Kurtz Jennifer A. (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits |
| Coq10 Arterial Stiffness Randomized Trial | Rather than providing an exhaustive account of all supplements ever studied, this review focuses on representative compounds with the strongest or most emerging human evidence. | 4 | Kurtz Jennifer A. (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits |
| Coq10 Arterial Stiffness Randomized Trial | Aging is a complex, multifaceted process marked by a gradual decline in physiological. | 4 | Kurtz Jennifer A. (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits |
Source documents